All (n = 7936 in each cohort) | Women (n = 3609 in each cohort) | Men (n = 4327 in each cohort) | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
gPop | ID | ID vs gPop | gPop | ID | ID vs gPop | gPop | ID | ID vs gPop | ||
n (%) | n (%) | RR (95% CI) | n (%) | n (%) | RR (95% CI) | n (%) | n (%) | RR (95% CI) | p | |
Diabetes mellitus | ||||||||||
Diagnosis (all) | 616 (8) | 741 (9) | 1.20 (1.08–1.34) | 207 (6) | 350 (10) | 1.69 (1.42–2.01) | 409 (9) | 391 (9) | 0.96 (0.83–1.10) | <0.001 |
Diagnosis (insulin-dependent) | 174 (2) | 182 (2) | 1.05 (0.85–1.29) | 67 (2) | 78 (2) | 1.16 (0.84–1.61) | 107 (2) | 104 (2) | 0.97 (0.74–1.27) | 0.40 |
Diagnosis (non-insulin-dependent) | 546 (7) | 664 (8) | 1.22 (1.09–1.36) | 186 (5) | 311 (9) | 1.67 (1.39–2.01) | 360 (8) | 353 (8) | 0.98 (0.85–1.14) | <0.001 |
Prescription | 805 (10) | 1013 (13) | 1.26 (1.15–1.38) | 273 (8) | 487 (13) | 1.78 (1.54–2.07) | 532 (12) | 526 (12) | 0.99 (0.88–1.12) | <0.001 |
Diagnosis and prescription | 541 (7) | 671 (8) | 1.24 (1.11–1.29) | 179 (5) | 314 (9) | 1.75 (1.46–2.11) | 362 (8) | 357 (8) | 0.99 (0.85–1.14) | <0.001 |
Diagnosis and/or prescription | 880 (11) | 1083 (14) | 1.23 (1.13–1.35) | 301 (8) | 523 (14) | 1.74 (1.51–2.00) | 579 (13) | 560 (13) | 0.97 (0.86–1.09) | <0.001 |
Hypertension | ||||||||||
Diagnosis | 1487 (19) | 814 (10) | 0.55 (0.50–0.60) | 629 (17) | 358 (10) | 0.57 (0.50–0.65) | 858 (20) | 456 (11) | 0.53 (0.47–0.60) | 0.44 |
Prescription | 3812 (48) | 3501 (44) | 0.92 (0.88–0.96) | 1715 (48) | 1689 (47) | 0.99 (0.92–1.05) | 2097 (48) | 1812 (42) | 0.86 (0.81–0.92) | 0.005 |
Diagnosis and prescription | 1457 (19) | 795 (10) | 0.55 (0.50–0.60) | 516 (17) | 348 (10) | 0.57 (0.50–0.64) | 841 (19) | 447 (10) | 0.53 (0.47–0.60) | 0.49 |
Diagnosis and/or prescription | 3842 (48) | 3520 (44) | 0.92 (0.88–0.96) | 1728 (48) | 1699 (47) | 0.98 (0.92–1.05) | 2114 (49) | 1821 (42) | 0.86 (0.81–0.92) | 0.005 |